Aspect Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.24K Hold
104
– – ﹤0.01% 287
2026
Q2
$8.95K Sell
104
-5
-5% -$438 ﹤0.01% 301
2026
Q1
$9.9K Hold
109
– – ﹤0.01% 265
2025
Q4
$9.8K Buy
109
+7
+7% +$664 ﹤0.01% 274
2025
Q3
$10K Hold
102
– – ﹤0.01% 299
2025
Q2
$9.3K Sell
102
-2
-2% -$193 ﹤0.01% 293
2025
Q1
$11.8K Hold
104
– – 0.01% 243
2024
Q4
$11K Hold
104
– – 0.01% 269
2024
Q3
$11.2K Hold
104
– – 0.01% 257
2024
Q2
$11.3K Hold
104
– – 0.01% 246
2024
Q1
$13.7K Hold
104
– – 0.01% 231
2023
Q4
$12.7K Buy
+104
New +$11.6K 0.01% 229

Other funds holding ZBH

Aspect Partners's ZBH Position: Q3 2026 in Review

Aspect Partners held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 104 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Aspect Partners first reported a position in ZBH in Q4 2023 and has held it in 12 quarters since. The position peaked at $13.7K in Q1 2024. 198 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Aspect Partners held 104 shares of Zimmer Biomet worth $9.24K as of Q3 2026.
  • Aspect Partners left its Zimmer Biomet share count unchanged in Q3 2026.
  • Zimmer Biomet made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #287 holding.
  • Aspect Partners first reported a position in Zimmer Biomet in Q4 2023 and has held it in 12 quarters since.
  • Aspect Partners's Zimmer Biomet position peaked at $13.7K in Q1 2024.
  • 198 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.